The Fraunhofer Institute For Toxicology And Experimental Medicine ITEM — Clinical Trial Site

9 Registered trials

3 Currently recruiting

Organisation

The Fraunhofer Institute For Toxicology And Experimental Medicine ITEM

Location

Hanover, Germany

Identifier

ORG-100013172

Address

Nikolai-Fuchs-Strasse 1, Gross Buchholz, 30625, Germany

Departments

#001:Toxicology and Experimental Medicine Clinical Airway Research
#2605:Clinical Airway Research
2603: Pneumology
Clinical Airway Research
Division of Clinical Airway Research
Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM)
Fraunhofer Institute for Toxicology and Experimental Medicine ITEM Clinical Airway Research
N/A
The Fraunhofer Institute For Toxicology And Experimental Medicine ITEM

Clinical trials at this site (9)

Search interface

A study to compare the relative potency of salbutamol administered via metered dose inhalers containing propellants HFA-152a to HFA-134a in … Pending

2024-511220-14-00 Mild Asthma 3
A study to investigate the effect of BGF MDI compared with placebo MDI on heart and lung function in participants with COPD Recruiting

2025-521987-37-00 Chronic Obstructive Pulmonary Disease 6 2025-11-06
Study of the compound RCS-21 on the safety of healthy volunteers, its tolerability and on the way the body absorbs, distributes, and gets ri… Recruiting

2024-512351-21-00 Safety, tolerability and pharmacokinetics of single-as 1 2024-12-10
A Phase 1 Study to Investigate the Safety and Tolerability of the Study Drug GB-0895 in Mild to Moderate Asthma Patients or Single Dose in C… Recruiting

2023-507611-35-00 mild to moderate asthma 1 2024-03-01
Study to assess the safety and tolerability of CMR316 in healthy volunteers and patients with Idiopathic Pulmonary Fibrosis. Ended

2023-510456-23-00 Idiopathic Pulmonary Fibrosis 1 2024-08-14
A Study to Assess the Safety, Tolerability and Immunological Response of ASP2390 in Adult Subjects Allergic to House Dust Mites Ended

2022-500660-35-00 Allergy to House Dust Mites 1 2020-02-17
A Phase Ib, Multicentre, Randomised, Single-blind, Parallel-group, Placebo-controlled, Study to Characterise the Pharmacokinetics and Pharma… Ended

2024-516474-30-00 Asthma 3 2025-02-19
A clinical study investigating OM-85-IN safety and tolerability in healthy volunteers and mild allergic asthma patients Ended

2022-503053-19-00 Mild allergic asthma 1 2024-06-14
A double-blind, placebo-controlled, parallel-group study to evaluate the safety and efficacy of briquilimab in participants with allergic a… Ended

2024-516164-28-00 allergic asthma 3